As of 2024-12-11, the Intrinsic Value of Greenwich Lifesciences Inc (GLSI) is
-3.99 USD. This GLSI valuation is based on the model Peter Lynch Fair Value.
With the current market price of 13.47 USD, the upside of Greenwich Lifesciences Inc is
-129.65%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-3.99 USD
Intrinsic Value
GLSI Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-3.99 - -3.99 |
-3.99 |
-129.65% |
| P/E |
(17.52) - (16.39) |
(18.73) |
-239.1% |
| DDM - Stable |
(5.13) - (30.17) |
(17.65) |
-231.0% |
| DDM - Multi |
(1.96) - (9.51) |
(3.30) |
-124.5% |
GLSI Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
177.00 |
| Beta |
1.42 |
| Outstanding shares (mil) |
13.14 |
| Enterprise Value (mil) |
171.17 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.64% |
| Cost of Debt |
5.00% |
| WACC |
7.16% |